Introduction
Mutations in the NF1 gene cause neurofibromatosis type 1 (NF1), a common dominantly inherited disease that occurs in one out of 3500 individuals worldwide. The NF1 gene encodes the tumor-suppressor protein neurofibromin that harbors a functional Ras-guanosine triphosphatase-activating protein (GAP) domain (Ballester et al., 1990; Xu et al., 1990) . Individuals with NF1 are predisposed to certain tumors, including benign neurofibromas, malignant peripheral nerve sheath tumor (MPNST), pheochromocytoma, astrocytoma, and juvenile myelomonocytic leukemia (Side and Shannon, 1998) , that occur in the context of Nf1 heterozygous (Nf1 þ /-) tissues. The hallmark feature is neurofibromas, and plexiform neurofibromas and MPNST (often arising from plexiform tumors) can be life threatening. To date, there are no reliable medical treatments to prevent or attenuate their growth. In the peripheral and central nervous system, biallelic Nf1 inactivation in Schwann cells or astrocytes can initiate tumor formation in the presence of Nf1 þ /-cells, suggesting an important role of Nf1 þ /-stromal cells in promoting tumor formation (Zhu et al., 2002; Bajenaru et al., 2003; Wu et al., 2005) .
Because solid tumor foci cannot expand without angiogenesis to create new blood vessel supply, antiangiogenic therapies have been pursued as potential strategies for cancer treatment. Targeting endothelial cells rather than actual tumor cells is widely applicable to various tumors, especially slow growing neoplasms like neurofibromas that do not respond to conventional cancer treatments. Also, antiangiogenic therapy may be particularly relevant to neurofibromas because they are highly vascularized (Arbiser et al., 1998; Morello et al., 2001; Wolkenstein et al., 2001) . Neurofibromin-deficient Schwann cells have increased Ras activity and a heightened angiogenic potential which most likely promotes vascularization and growth of NF1 tumors (Sheela et al., 1990) . Angiogenic properties have been described for Nf1 null Schwann cells derived from NF1 tumors and Nf1 knockout mice (Sheela et al., 1990; Kim et al., 1997; Mashour et al., 1999 Mashour et al., , 2001 , and from their xenografts and syngrafts in mice models (Duprez et al., 1991; Wu et al., 2005) . Although NF1 heterozygosity has been implicated in the growth of NF1 tumors, its contribution to vascularization and associated cellular responses remains speculative.
We report here that Nf1 heterozygous endothelial cell cultures have an exaggerated proliferative response to several angiogenic factors. Moreover, Nf1 heterozygous mice show greater angiogenesis in response to various angiogenic stimuli in both the retinal neovascularization (NV) and corneal NV models. We also found that increased corneal NV was associated with heightened endothelial cell proliferation and migration, and elevated infiltration of inflammatory cells including macrophages and mast cells.
Results

Nf1
þ /-mice exhibit an exaggerated ischemia-induced retinal neovascular response To determine whether Nf1 heterozygosity affects angiogenic responses, we used a mouse retinal NV model, which has been routinely used for retinopathy studies (Raisler et al., 2002) . In response to hypoxia condition, retinas from heterozygous mice had more neovascular endothelial cells associated with aberrant microvessels penetrating the internal limiting membrane (Figure 1a ) than wild-type mice. Quantitative scoring indicated that Nf1 þ /-retinas (n ¼ 25) had significantly increased (52%) neovascularity compared to Nf1 (Figure 1b) . However, in the control condition (normoxia), the age-matched mice showed no significant difference in their baseline retinal NV between the two genotypes examined (n ¼ 8 each) (data not shown), indicating that Nf1 þ /-mice are free of intrinsic aberrant retinal NV. With baseline correction (subtracting the score of control mice from those of treated mice), Nf1 þ /-mice showed a 66% increase in retinal NV compared to wild-type mice. These data indicate that Nf1 heterozygosity may, in general, exaggerate the angiogenic response.
þ /-mice exhibit an exaggerated corneal neovascular response Next, we examined the angiogenic response of Nf1 þ /-mice in the mouse corneal NV model. We first examined the specificity of the corneal NV response to micropellets implanted with bFGF. Pellets containing 0, 31 and 90 ng of bFGF were implanted into the corneas of Nf1 þ /-mice. After 6 days, corneas implanted with pure pellet showed no vessel formation (not shown). Corneas implanted with bFGF-impregnated pellets induced abundant new blood vessel growth extending from limbal vessels and advancing toward the implantation site ( Figure 2a ). Confocal fluorescence microscopy of CD31 immunostained corneas showed markedly greater NV (both maximum new vessel length and outgrowth circumference) in response to 96 ng bFGF (Figure 2b ) compared to 31 ng pellets (Figure 2c ). These data confirmed that the corneal NV induced in Nf1 þ /-mice is bFGF specific and dose dependent, and thus may provide a sensitive and reliable means to assess the effect of Nf1 haploinsufficiency on angiogenesis. The higher dose pellets were used in all subsequent testing.
Corneal NV induced by bFGF was compared between Nf1 þ /-and Nf1 þ / þ mice. At 6 days after implantation the corneal NV in Nf1 heterozygous mice was conspicuously greater than that found in wild-type littermates (Figure 2b and d) . The maximum new blood vessel length in corneas of Nf1 heterozygous mice was 67% greater than that of wild-type controls (P ¼ 0.00002, n ¼ 13) (Figure 2e ). There was no significant difference in the circumferences of NV (Figure 2f ) or in the NV response 4 days after bFGF implantation (data not shown) between Nf1 heterozygous and wild-type littermates. These findings indicate that the effect of Nf1 heterozygosity on angiogenesis is cumulative and complex (not a simple dose response). Taken together, the results obtained using two in vivo assays provide convincing evidence that Nf1 haploinsufficiency significantly increased the angiogenic response to hypoxia or bFGF, without nonspecific baseline effects.
Corneal NV is associated with greater endothelial cell proliferation in Nf1
þ /-mice We tested the hypothesis that heightened endothelial cell proliferation is associated with the corneal NV response in Nf1 haploinsufficient mice. At 6 days after bFGF implantation, endothelial cell proliferation was assessed in cross-sections of corneas from Nf1 heterozygous and wild-type littermates by double labeling for Ki67 and CD31. In the entire region from the limbus to the pellet site, more than twice the number of proliferating endothelial (double labeled) cells was observed in the corneas of Nf1 heterozygous mice compared to wildtype mice (P ¼ 0.001, n ¼ 8) (Figure 3a ). The greatest difference was found in more distal zones from the limbus, where the number of proliferating CD31-positive cells was more than fivefold greater in Nf1 þ /-corneas than in wild-type controls. These results indicate that endothelial cell proliferation and migration in response to bFGF is exaggerated by Nf1 haploinsufficiency.
We then examined the response of Nf1 þ /-endothelial cells to mitogens in vitro. Endothelial cell cultures were established from microvessels isolated from Nf1 þ /-and wild-type littermates. Endothelial cell phenotype was confirmed by immunoexpression of Von Willebrand's Factor and abundant tube formation in Matrigel threedimensional culture (results not shown). In a base medium (containing serum but no endothelial cell mitogen supplements) approximately 5% of the wild-type endothelial cells had BrdU-positive nuclei increased the BrdU-DNA to 13% for wild-type and 27% for Nf1 þ /-endothelial cultures. VEGF treatment caused a similar but less pronounced differential response. bFGF was a potent mitogen and more than doubled the proliferation of wild-type endothelial cells over that seen in the base medium alone. The response to bFGF by Nf1 þ /-endothelial cells was 3.6-fold greater than in base medium and nearly equaled that with the pituitary growth supplement. Overall, the response of Nf1 þ /-endothelial cells to mitogens was approximately double that exhibited by wild-type cells. These findings indicate that Nf1 heterozygous endothelial cells had an exaggerated mitogenic response that most likely contributes to the increased angiogenic potential observed in the corneal and retinal assays.
Corneal NV is associated with increased infiltration of inflammatory cells in Nf1 þ /-mice Next, to test the hypothesis that Nf1 þ /-inflammatory cells might be involved in the increased angiogenic response in Nf1 þ /-mice, we examined the infiltration by macrophages and mast cells in corneal cross-sections adjacent to those used for endothelial cell proliferation assays described above. Mac-1 immunostaining of wildtype corneas showed substantial baseline macrophage infiltration of the corneal and a high macrophage density around the pellet, consistent with observations reported previously (Kenyon et al., 1996) . Counts of Mac-1 immunopositive cells revealed macrophage infiltration was significantly elevated locally in Nf1 þ /-corneas after bFGF implantation. Nf1 þ /-corneas exhibited a pattern of macrophage infiltration as similar to that in wild-type corneas in avascular area. However, in the NV zone, the number of macrophage was 4.6-fold greater in Nf1 þ /-corneas than wild-type corneas (Figure 4a ). The increase in macrophage cell density was most pronounced near the limbal vessels and in general lagged well behind the leading front of the þ /-mice exhibit increased growth factor-induced corneal neovascularization. Micropellets impregnated with bFGF were implanted into the corneal stroma of Nf1 þ /-(a-c) and
At 6 days postimplantation an intense neovascular response was seen originating from the limbal vessels and extending to the pellet (*) (a). Neovascularization was observed by fluorescence confocal microscopy of CD31-immunostained corneal flat-mounts 6 days after implantation of micropellets containing 96 ng (b and d) and 31 ng (c) bFGF. Corneal NV was quantified by measuring the maximum vessel length (e) extending from the base of the limbal vascular plexus toward the pellet and the maximum contiguous circumference (f) along the base of the limbal of neovascularization zone. Data represent the means ( þ s.e.; n ¼ 13) obtained from three independent experiments. Original magnification: Â 100 (b-d). þ /-and wild-type endothelial cell cultures were treated with a base medium (80% DMEM/F12, 10% horse plasma-derived serum, 10% fetal bovine serum, and 100 mg/ml heparin) or base medium containing either VEGF (50 ng/ml), bFGF (50 ng/ml), or endothelial cell growth supplement (100 mg/ml). Data represent the means ( þ s.e.) of more than eight replicates for each condition performed in two separate assays on two independent culture preparations.
Angiogenesis in Nf1 haploinsufficiency M Wu et al growing blood vessels. Similarly, c-Kit immunostaining revealed a 63% increase in mast cell infiltration in the neovascularized area of Nf1 þ /-corneas compared to wild-type corneas (P ¼ 0.005, n ¼ 8) (Figure 4a ). In general, the number of inflammatory cells was directly correlated with the amount of NV.
We also examined the effect of scid background (T-and B-cell deficiency) on the angiogenic response of Nf1 þ /-mice by comparing bFGF-induced corneal NV between mice with different genetic backgrounds, inclu- (Figure 4b ). At 6 days after bFGF implantation, the corneal NV in both scid and B6 mice were augmented due to Nf1 þ /-haploinsufficiency (which advanced an average of 0.25 mm for scid mice and 0.28 mm for B6 mice). Although the scid mice had relatively lower level of corneal NV than B6 mice of the same genotype, the reduction is only statistically significant under the condition of Nf1 haploinsufficiency (Nf1 þ /-/B6 mice was 24% greater than in Nf1 þ /-/scid, n ¼ 4 and 13, respectively, P ¼ 0.02). On the other hand, Nf1 þ / þ /scid and Nf1 þ / þ /B6 mice showed no significant difference in their corneal NV (n ¼ 10 and 13, respectively, P ¼ 0.06), confirming results reported previously by Kenyon et al. (1996) . Thus, the reduced corneal NV in Nf1
/B6 mice may be due to the lack of haploinsufficient phenotypes of B lymphocytes, which is known to contribute to angiogenic responses in the tumor microenvironment (de Visser et al., 2005) . Overall the reduced level of corneal NV due to the scid background is limited compared to the effect of Nf1 haploinsufficiency, suggesting that Nf1 þ /-B lymphocytes can contribute a minor additive effect to angiogenesis.
Discussion
Transgenic and syngraft studies show that Nf1 null Schwann cells give rise to neurofibromas in Nf1 haploinsufficient mice (Zhu et al., 2002; Wu et al., 2005) . Although the Nf1 heterozygous background is also implicated in neurofibroma formation, the underlying mechanisms remain unknown. Given the essential role of angiogenesis in solid tumor growth, we hypothesized that Nf1 heterozygosity can result in different angiogenic responses to various stimuli, particularly those associated with neurofibroma development. Initially we found that Nf1 þ /-mice showed a marked increase in hypoxia-induced retinal NV compared to that of wild-type mice. This finding is consistent with a recent report by Ozerdem (2004) using the same neonatal hypoxia model. Additionally, our study showed that there was no significant difference in normal (developmental) retinal NV between Nf1 þ /-and wild-type mice. Neither study ruled out the possibility that an exaggerated retinal NV in response to ischemia in Nf1 þ /-mice is mainly a developmental disposition. To that end and to corroborate these findings in a more valid model of NV, we found that adult Nf1 þ /-mice showed an elevated neovascular response to a single angiogenic factor (bFGF) applied to the cornea. Based on these results we conclude that Nf1 heterozygosity augments angiogenesis.
Although NF1 is characterized by hyperproliferation and neoplasia of neural crest derivatives, affected individuals often have disorders that seem less related to the neural crest, including hypertension, renal artery stenosis, increased incidence of congenital heart disease, and vascular disorders (Hamilton et al., 2001; Rasmussen et al., 2001; Friedman et al., 2002) . As neurofibromin is expressed in blood vessel endothelial and smooth muscle cells, Hamilton and Friedman (2000) suggested that NF1 vasculopathy might result from an alteration of neurofibromin function in these cells. Indeed, transgenic mice with endothelial-specific inactivation of Nf1 recapitulate key aspects of the complete null phenotype, including multiple cardiovascular abnormalities involving the endocardial cushions and myocardium (Gitler et al., 2003) . This phenotype is associated with elevated Ras signaling in Nf1 -/-endothelial cells and greater nuclear localization of the transcription factor NFATC1. Similarly, we find that mouse Nf1 þ /-endothelial cells have an exaggerated response to mitogens in vitro and increased migration and proliferation in response to bFGF in vivo. This disposition of Nf1 haploinsufficient endothelial cells surely contributes to the heightened angiogenesis induced by hypoxia and angiogenic factor stimulation we observed, and may also contribute to the NF1 features described above, possibly in association with increased Ras activation.
Macrophage and mast cells, in addition to their role in inflammation, are now recognized as potential epigenetic contributors to cancer and angiogenesis (Coussens and Werb, 2001; Mueller and Fusenig, 2004) . In the corneal angiogenesis model, macrophage and mast cell infiltration might occur as part of an inflammatory response caused by the implantation of the bFGF pellet or as part of the angiogenic response to bFGF per se. In developing the corneal angiogenesis model, Kenyon et al. (1996) sought to exclude inflammation as an angiogenic stimulus. They documented that the inflammatory cellular activity caused by pellet implantation was minimal and resolved within the first 2 days and prior to any observable NV. This indicates that angiogenesis did not occur as a secondary effect to inflammation and that macrophage and mast cell infiltration was not sustained by bFGF itself. Our studies were in agreement with their observation, indicating that infiltrating macrophages and mast cells appeared not to instigate angiogenesis. This was particularly evident in the exaggerated angiogenic response in Nf1 haploinsufficient mice, whereby inflammatory cell density was increased but in areas well behind the leading edge of growing blood vessels. We conclude that the infiltration of inflammatory cells is elevated in Nf1 þ /-corneas and this response is positively correlated with, and likely secondary to, the overall exaggerated angiogenic response.
In tumor development inflammatory cells express a range of proteases and proangiogenic factors including bFGF and VEGF that can promote and sustain tumor progression and angiogenesis. Although the role of macrophages in neurofibroma formation is not characterized, they are more abundant in neurofibromas and MPNSTs than schwannomas (Johnson et al., 1989) . Also, mast cells show marked infiltration in neurofibromas and have been considered as a major player in neurofibroma formation (Riccardi, 1981; Johnson et al., 1989; Ingram et al., 2000 Ingram et al., , 2001 . Recent studies showed that Nf1 þ /-mast cells have increased survival and proliferation, and are hypermotile compared to wildtype cells in response to stem cell factor expressed by Nf1 þ /-Schwann cells, specifically on a 4 b 1 integrins in response to Kit ligand (KitL) and linked with Ras-class I A -PI3K-Rac2 pathway. Reintroduction of the GAPrelated domain into Nf1 þ /-mast cell reduces their migration to wild-type levels in response to KitL, providing direct evidence that an Nf1 þ /-motile phenotype is secondary to hyperactivation of Ras pathway (Ingram et al., 2000 (Ingram et al., , 2001 Yang et al., 2003) .
Loss of NF1 expression results in impaired neurofibromin-mediated Ras inactivation and leads to increased Ras pathway activation and tumorigenesis.
Activation of Ras in Schwann cells derived from Nf1
-/-mice and human NF1 tumor has been shown to have increased secretion of soluble factors such as bFGF and KitL (Hirota et al., 1993; Mashour et al., 2001; Yang et al., 2003) , which can stimulate proliferation and migration of endothelial and inflammatory cells. Recent studies show that one of the contributions of the stroma to tumor progression is the expression of angiogenic growth factors including VEGF, bFGF, PDGF and others by macrophages, mast cells and other leukocytes. Increased expression of these growth factors is often associated with Ras activation (see review Mueller and Fusenig, 2004) . Thus, we can expect that activation of Nf1 þ /-endothelial cells, mast cells, macrophages and other cell types (e.g. fibroblasts and bone marrowderived hematopoietic stem cells) that contribute to angiogenesis may have exaggerated expression and response to proangiogenic factors, most likely in association with hyperactivation of Ras. Our studies demonstrate clearly the association of Nf1 haploinsufficiency in multiple cell types (including inflammatory and endothelial cells) with an exaggerated angiogenic response. These findings may also improve our understanding of the role of haploinsufficiency in angiogenesis and the growth of neurofibroma, leading to possible interventions using antiangiogenic therapies.
Materials and methods
Animals
Our stock colony of Nf1 knockout mutant mice (B6/Nf1) (Brannan et al., 1994) was produced by in-breeding of mice onto the C57BL/6 background. Mice (Nf1/scid) with an Nf1 heterozygous background that were also immunodeficient were generated by cross-breeding B6/Nf1 and B6/scid mice (Wu et al., 2005) and are heretofore referred to as Nf1 mice. The original scid mice were obtained from the Jackson Laboratory (Bar Harbor, ME, USA). All methods and animal uses were performed in accordance to the Animal Care and Use Guidelines of the University of Florida College of Medicine.
Genotyping
The Nf1 locus was genotyped by a 3-oligo system PCR, as described by Brannan et al. (1994) . The scid mutation in the DNA-PKCS gene (a nonsense mutation) was described by Blunt et al. (1996) . Based on genomic DNA sequence (Genbank AB005213), we developed a PCR-based genotype assay. PCR primers were designed flanking the mutation site in exon 85: scid 5 0 (GAGTTTTGAGCAGACAATGCTGA) and scid 3 0 (CTTTTGAACACACACTGATTCTGC). The resulting 180 bp PCR product was digested with Alu I to distinguish wild-type allele (no cut) from mutant allele (cut) via agarose gel electrophoresis, to genotype animals at the scid locus.
Endothelial cell culture
Cultures of murine brain microvascular endothelial cells were obtained by modifications of the methods described by Song and Pachter (2003) . Briefly, cortical gray matter free of nerves, meninges and choroid plexus was isolated from six 3-5-weekold mice. The cortices were maintained in ice-cold medium and minced into 1 mm pieces. The tissue was homogenized first in a Dounce homogenizer by 30 strokes of a larger clearance pestle ('A' pestle) followed by 25 strokes using the smaller clearance pestle ('B' pestle). The homogenate was centrifuged at 200 g for 5 min at 11C and the supernatant was discarded. The tissue pellet was resuspended in 15 ml of isotonic 18% (wt/vol) dextran solution and centrifuged at 10 000 g for 10 min. The tissue pellet was resuspended in 5 ml of Hank's balances salt solution (Ca 2 þ and Mg 2 þ free) and then passed through a 70-mm nylon mesh screen mounted on a syringe barrel. The microvessel fraction retained by the screen was harvested in medium and collected by centrifugation at 200 g for 5 min. The microvessels were gently resuspended in 5 ml of Digestion medium containing Hank's, 0.1 U/ml collagenase (type XI, Sigma), 0.8 U/ml Dispase (Collaborative Research), 20 U/ml DNase-1 (Type II-Sterile, Sigma), 0.4 mM tosyl-lysine chloromethyl ketone (Sigma). The mixture was placed in a 60-mm Petri dish and incubated at 371C in a 5% CO 2 /air incubator for 90 min with occasional agitation. By the end of the digestion, endothelial cells start popping out from the vessel fragments, appearing as beads on a string. The digestion should not proceed to the single-cell level. The partially digested microvessel fragments were collected and resuspended in Growth Medium containing 80% DMEM/F12 (14.3 mM sodium bicarbonate, 20 mM HEPES, pH 7.4), 10% horse plasmaderived serum (Atlanta Biologicals), 10% fetal bovine serum, 100 mg/ml heparin, 100 mg/ml endothelial cell growth supplement (BD Biosciences) and antibiotics. The suspension was seeded onto tissue culture dishes coated with murine collagen IV (50 mg/ml in 0.05 N HCl) (BD Biosciences). The cultures were passaged when confluent by incubating in Hank's solution containing 10 mM EDTA until the cells appeared rounded. The trypsin (0.05%)/EDTA (0.5 mM) was added for 30 s and the cells detached by tapping the dish. The trypsin was neutralized by the addition of medium containing serum and the remaining cells were dislodged by squirting the medium. The suspension was diluted with Growth Medium and passaged 1:5 into collagen IV-coated dishes.
In vitro proliferation assay First passage endothelial cell cultures (5000 cell/well) were seeded into 96-well plates coated with collagen IV and fed a base medium (80% DMEM/F12, 10% horse plasma-derived serum, 10% fetal bovine serum, and 100 mg/ml heparin). After 4 h the cultures were treated with the base medium alone or the base medium containing either endothelial cell growth supplement (100 mg/ml), vascular endothelial cell growth factor (50 ng/ml VEGF 165 , R&D Systems), or basic fibroblast growth factor bFGF (50 ng/ml, R&D Systems). At 24 h after treatments, the medium was brought to 10 mg/ml with bromodeoxyuridine (BrdU) and cultured for an additional 24 h. Fixed cultures were immunolabeled for BrdU-positive DNA and the percentage of cells with BrdU-DNA were scored as described previously (Muir et al., 1990) .
Induction of angiogenesis by hyperoxia
Mouse pups derived from Nf1 þ /-/scid females bred with Nf1 þ / þ /scid males, with their nursing dam, were placed in a chamber containing 75% oxygen at postnatal day 7 (P7). At 5 days after oxygen treatment, the P12 pups and nursing dam were returned to normal room air and maintained for another 5 days. These pups were terminated at P17 under anesthesia by an overdose of ketamine/xylazine, and their eyes were enucleated and fixed for retinal NV assessment.
Quantification of retinal NV
Retinal NV was scored by methods described by Smith et al. (1994) . Briefly the enucleated eyes were immersed in 4% paraformaldehyde in PBS for at least 24 h, and embedded in paraffin. Serial sections (5 mm) of whole eyes were cut through the full eyecup parallel to the optic nerve. Representative sections (every 30th section) were stained with hematoxylin and eosin and vascular endothelial cell nuclei outside the internal limiting membrane were counted by trained investigators masked to the identity of each section. Such vascular cell nuclei, on the vitreous side of the internal limiting membrane identified in this protocol, were considered to be associated with NV and provide a reliable evidence for quantitatively assessing the total level of retinal NV in each eye.
Induction of corneal angiogenesis by bFGF micropellets
Young adult mice (8-14 weeks), litters of both Nf1 þ /-/scid and Nf1 þ / þ /scid mice, were anesthetized by intraperitoneal (i.p.) injection of 0.1 ml per 20 g body weight of anesthetic cocktail containing ketamine (12.5 mg/ml) and xylazine (2.5 mg/ml). Both eyes were topically anesthetized with 0.5% proparacaine (Ophthetic, Alcon, TX, USA), and a corneal micropocket (approximately 0.7 mm length) was dissected with a surgical blade and needle (30G1/2) (Sun Surgical). A micropellet (0.5 Â 0.5 Â 0.2 mm 3 ) of sucralfate and hydron polymer containing bFGF (80 mg or as indicated) was placed into the pocket and advanced to end of the pocket, which extended to within 0.8-1.0 mm of temporal limbus. Antibiotic ointment (erythromycin) (Sun Surgical) was applied postsurgically to the eyes.
Quantification of corneal NV At 4-6 days after implantation, mice were anesthetized by i.p. injection of ketamine/xylazine mixture. Corneal NV extending from the base of the limbal vascular plexus toward the pellet was measured under standard microscopy (Kenyon et al., 1996) . Eyes were then enucleated and immersed in 4% paraformaldehyde in PBS for 20 min. Eyes showing any abnormal phenotype such as opacity were excluded from further analysis.
Immunohistochemical staining for vascular endothelial cells was performed on corneal flat mounts. Corneas with part of limbal vascular attached were dissected from enucleated eyes and rinsed with PBS and fixed in 100% acetone for 20 min. After washing in PBS, nonspecific binding was blocked with 0.1 M PBS, 2% albumin for 2 h at room temperature. Corneas were incubated at 41C for 24 h in primary antibody, fluorescein isothiocyanate-conjugated rat anti-mouse CD31 (FITC-CD31) (BD Pharmingen) diluted 1:500 in blocking buffer. After several washes in PBS at room temperature corneas were mounted on slides and coverslipped with Vectashield (Vector Laboratories Inc., Burlingame, CA, USA). Images of CD31-stained corneal vasculature were captured by confocal fluorescence microscopy. Corneal NV was quantified by measuring the maximum vessel length extending from the base of the limbal vascular plexus toward the pellet and the maximum contiguous circumference along the base of the limbal of NV zone using Image-Pro Plus software.
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